Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

OBJECTIVES: Moxifloxacin (MXF) has been advocated for the treatment of extensively drug-resistant (XDR) tuberculosis despite resistance to older-generation fluoroquinolones. We investigated the relationship between the minimum inhibitory concentration (MIC) of MXF and mutations in the gyrA and gyrB...

Descripción completa

Detalles Bibliográficos
Autores principales: Dookie, Navisha, Sturm, A Willem, Moodley, Prashini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149401/
https://www.ncbi.nlm.nih.gov/pubmed/25187730
http://dx.doi.org/10.2147/IDR.S65417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149401/
https://www.ncbi.nlm.nih.gov/pubmed/25187730
http://dx.doi.org/10.2147/IDR.S65417

Ejemplares similares